Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

672130

registered interest
date	12/01/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Breast Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will estimate the effect of making available on the NHS bisphosphonates for the treatment of secondary breast cancer on the number of women successfully treated for breast cancer each year.
tabling member constituency	Belfast North
tabling member printed	Mr Nigel Dodds
uin	59813
answer	answer is ministerial correction date of answer 20/01/2017 answer text <p>Information is not available to enable such an estimate to be made.</p><p> </p><p>Although bisphosphonates are not licensed for the treatment or prevention of secondary breast cancer, there is no legal or regulatory barrier to healthcare professionals prescribing them ‘off-licence’ for this purpose on the National Health Service, subject to any local funding policies, if they believe that it is clinically appropriate to do so.</p><p> </p><p>In its clinical guideline on the diagnosis and treatment of early and locally advanced breast cancer (CG80), published in February 2009, the National Institute for Health and Care Excellence (NICE) recommends that bisphosphonates should be offered to patients for the management of breast cancer treatment-induced bone loss subject to certain criteria. NICE is currently updating this guidance and the use of adjuvant bisphosphonates is one of the key areas that will be covered in the update which is expected in July 2018.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 20/01/2017 13:56:40 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1388 label Biography information for Lord Dodds of Duncairn

672131

registered interest
date	12/01/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Breast Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what research his Department has undertaken into the barriers clinicians experience in prescribing bisphosphonates for the prevention of secondary breast cancer.
tabling member constituency	Belfast North
tabling member printed	Mr Nigel Dodds
uin	59856
answer	answer is ministerial correction date of answer 20/01/2017 answer text <p>No such research has been undertaken.</p><p> </p><p>Although bisphosphonates are not licensed for the treatment or prevention of secondary breast cancer, there is no legal or regulatory barrier to healthcare professionals prescribing them ‘off-licence’ for this purpose on the National Health Service, subject to any local funding policies, if they believe that it is clinically appropriate to do so.</p><p> </p><p>In its clinical guideline on the diagnosis and treatment of early and locally advanced breast cancer (CG80), published in February 2009, the National Institute for Health and Care Excellence (NICE) recommends that bisphosphonates should be offered to patients for the management of breast cancer treatment-induced bone loss subject to certain criteria. NICE is currently updating this guidance and the use of adjuvant bisphosphonates is one of the key areas that will be covered in the update which is expected in July 2018.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 20/01/2017 13:55:04 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1388 label Biography information for Lord Dodds of Duncairn

672147

registered interest
date	12/01/2017
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Police: Emergency Calls
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what proportion of emergency calls to the police were responded to within 20 minutes in 2015-16.
tabling member constituency	Belfast North
tabling member printed	Mr Nigel Dodds
uin	59726
answer	answer is ministerial correction date of answer 20/01/2017 answer text <p>Responding to emergency calls is the responsibility of local police forces. Forces provide data to the Home Office on the number of 999 calls received but not on response times to 999 emergency calls.</p> answering member constituency Great Yarmouth answering member printed Brandon Lewis question first answered 20/01/2017 09:29:13 answering member 4009 label Biography information for Sir Brandon Lewis
tabling member	1388 label Biography information for Lord Dodds of Duncairn

658583

registered interest
date	14/12/2016
answering body	Northern Ireland Office
answering dept id	21
answering dept short name	Northern Ireland
answering dept sort name	Northern Ireland
hansard heading	Lough Foyle
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Northern Ireland, pursuant to the Answer of 13 December 2016 to Question 56613, whether the Government has had recent discussions with the government of the Irish Republic on ownership of Lough Foyle.
tabling member constituency	Belfast North
tabling member printed	Mr Nigel Dodds
uin	57558
answer	answer is ministerial correction date of answer 19/12/2016 answer text <p>I regularly engage with the Irish Government on a number of issues. The management of Lough Foyle is the responsibility of the Loughs Agency, a North-South body established under the Belfast Agreement. Discussions continue between the UK Government and the Irish Government on further improvements to the day to day management of the Lough.</p> answering member constituency Old Bexley and Sidcup answering member printed James Brokenshire question first answered 19/12/2016 15:18:53 answering member 1530 label Biography information for James Brokenshire
tabling member	1388 label Biography information for Lord Dodds of Duncairn

654480

registered interest
date	07/12/2016
answering body	Northern Ireland Office
answering dept id	21
answering dept short name	Northern Ireland
answering dept sort name	Northern Ireland
hansard heading	Lough Foyle
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Northern Ireland, what recent discussions the Government has had with the Government of the Irish Republic on ownership of Lough Foyle.
tabling member constituency	Belfast North
tabling member printed	Mr Nigel Dodds
uin	56613
answer	answer is ministerial correction date of answer 13/12/2016 answer text <p>The regulation of activities in Lough Foyle is the responsibility of the Loughs Agency, a cross-border body established under the Belfast Agreement of 1998. We remain fully committed to these arrangements and continue to work closely with the Irish Government over improvements to the management of the Loughs.</p><p> </p> answering member constituency Old Bexley and Sidcup answering member printed James Brokenshire question first answered 13/12/2016 14:16:56 answering member 1530 label Biography information for James Brokenshire
tabling member	1388 label Biography information for Lord Dodds of Duncairn

649494

registered interest
date	01/12/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Breast Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions his Department has had with the Northern Ireland Executive on (a) best practice and (b) other issues relating to the treatment of breast cancer by bisphosphonates; and if he will make a statement.
tabling member constituency	Belfast North
tabling member printed	Mr Nigel Dodds
uin	55802
answer	answer is ministerial correction date of answer 09/12/2016 answer text <p>Whilst officials in the Department engage regularly with the Northern Ireland Executive, no conversations have specifically been had on bisphosphonates.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 09/12/2016 10:23:52 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1388 label Biography information for Lord Dodds of Duncairn

648661

registered interest
date	30/11/2016
answering body	HM Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	CaTreasury
hansard heading	European Investment Bank
house id	1
legislature	25259 pref label House of Commons
question text	To ask Mr Chancellor of the Exchequer, what estimate he has made of the current value of the UK's share in the capital of the European Investment Bank.
tabling member constituency	Belfast North
tabling member printed	Mr Nigel Dodds
uin	55569
answer	answer is ministerial correction date of answer 07/12/2016 answer text <p>The total value of the European Investment Bank’s subscribed capital is €243.3bn. Of this just under €21.7bn is paid in capital and €221.6bn is callable capital. The breakdown of capital shares by country is set out in the EIB statutes and the EIB publishes annual financial reports.</p> answering member constituency South West Hertfordshire answering member printed Mr David Gauke question first answered 07/12/2016 11:19:15 answering member 1529 label Biography information for Mr David Gauke
tabling member	1388 label Biography information for Lord Dodds of Duncairn

648749

registered interest
date	30/11/2016
answering body	Ministry of Defence
answering dept id	11
answering dept short name	Defence
answering dept sort name	Defence
hansard heading	Iraq: Overseas Aid
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Defence, what additional in-country assistance the Government has disbursed to Iraq since the Warsaw NATO Summit in July 2016.
tabling member constituency	Belfast North
tabling member printed	Mr Nigel Dodds
uin	55568
answer	answer is ministerial correction date of answer 06/12/2016 answer text <p>The UK continues to assist Iraq in defeating Daesh. We have over 550 personnel in Iraq, assisting with training as part of the Global Coalition's Building Partner Capacity Programme. UK forces have helped to train over 30,000 Iraqi security forces personnel, including over 7,000 Kurdish Peshmerga. The RAF also continues to support the Coalition through participation in airstrikes. At the Warsaw Summit in July 2016, the UK pledged £1 million to help NATO shape its in-country training and capacity building initiative; this money will enable NATO training to start in January 2017.</p> answering member constituency Hemel Hempstead answering member printed Mike Penning question first answered 06/12/2016 14:06:55 answering member 1528 label Biography information for Sir Mike Penning
tabling member	1388 label Biography information for Lord Dodds of Duncairn

648795

registered interest
date	30/11/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Breast Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has been made of the effectiveness of bisphosphates in the treatment of breast cancer.
tabling member constituency	Belfast North
tabling member printed	Mr Nigel Dodds
uin	55717
answer	answer is ministerial correction date of answer 07/12/2016 answer text <p>We have made no such assessment.</p><p> </p><p>In its clinical guideline on the diagnosis and treatment of early and locally advanced breast cancer (CG80), published in February 2009, the National Institute for Health and Care Excellence (NICE) recommends that bisphosphonates should be offered to patients for the management of breast cancer treatment-induced bone loss subject to certain criteria.</p><p> </p><p>NICE is currently updating this guidance and the use of adjuvant bisphosphonates is one of the key areas that will be covered in the update which is expected in July 2018.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 07/12/2016 10:39:55 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1388 label Biography information for Lord Dodds of Duncairn

648938

registered interest
date	30/11/2016
answering body	Department for Exiting the European Union
answering dept id	203
answering dept short name	Exiting the European Union
answering dept sort name	Exiting the European Union
hansard heading	European Investment Bank
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Exiting the European Union, what discussions he has had with the Chancellor of the Exchequer on the future use of funding held as part of the UK share in the capital of the European Investment Bank.
tabling member constituency	Belfast North
tabling member printed	Mr Nigel Dodds
uin	55567
answer	answer is ministerial correction date of answer 08/12/2016 answer text <p>The Department is working closely with the Treasury and other Departments across Whitehall as we prepare our negotiating position. Collectively, we are working to ensure that people and businesses have stability and certainty in the period leading up to our departure from the EU and that we secure a deal in the best interests of the UK.</p><p> </p> answering member constituency Clwyd West answering member printed Mr David Jones question first answered 08/12/2016 14:59:10 answering member 1502 label Biography information for Mr David Jones
tabling member	1388 label Biography information for Lord Dodds of Duncairn